ArticleClinical interventions in aging2025
Machine Learning-Based Prediction of Post-PKP Frailty: A Retrospective Cohort Study.
Article in Clinical interventions in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Frailty and osteoporotic vertebral compression fractures (OVCFs) exhibit bidirectional causality, yet the impact of percutaneous kyphoplasty (PKP) on frailty progression remains unclear. This study developed machine learning (ML) models to predict post-PKP frailty and identify key predictors. Methods: A retrospective cohort of 4599 PKP patients was categorized into frailty/non-frailty groups based on two-year follow-up. Variables included preoperative baseline data, imaging parameters (fracture number/segments, Genant classification, T2 hyperintensity), clinical characteristics (osteoporosis severity, Visual Analogue Scale scores, residual low back pain [LBP]), and surgical details. After data splitting (4:1 ratio), features were selected to train and optimize ML models, with performance evaluated via area under the curve (AUC). The ML model with the best performance was selected as our final model while using it for external validation. SHAP analysis determined predictor contributions. Results: Key features (residual LBP, Genant classification, etc) informed model development. Hyperparameter optimization enhanced performance, with Extreme Gradient Boost achieving superior prediction (AUC 0.950, 95% CI 0.934-0.965). The model still maintains a good performance in the external test set, with an AUC of 0.845 (95% CI 0.805-0.884). SHAP identified residual LBP, Genant classification, and postoperative recumbency duration as top predictors. Conclusion: ML models effectively predict post-PKP frailty, highlighting modifiable risk factors. Standardized anti-osteoporosis therapy, residual LBP prevention, and reduced postoperative recumbency may mitigate frailty risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.